Skip to content

A multicenter, randomized, controlled clinical trial of the efficacy and safety of loquat Qingfei Decoction and traditional Chinese medicine in the treatment of Lung-Heat Type Acne

Chinese medicine formula particles national standard upgrade and comparative study of curative effect of clinical decoction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014263
Enrollment
Unknown
Registered
2018-01-02
Start date
2018-01-02
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung-Heat Type Acne

Interventions

treatment group:loquat Qingfei decoction granule (shineway brand)
control group:traditional decoction

Sponsors

Shijiazhuang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Meet Western diagnostic criteria for mild to moderate acne; (2) In line with Chinese acne lungs heat syndrome diagnostic criteria; (3) The age of 15-45 years old, duration of 3 months or more, gender is not limited; (4) Willing and able to cooperate with the treatment and sign the informed consent; (5) No oral medication related to this disease was used within 30 days before treatment; external drug related to this disease was not used within 7 days.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Allergic or allergic to drug components; (3) Patients with severe primary diseases of cardiovascular, liver, kidney, brain, endocrine and hematopoietic system complicated by hypertension, diabetes, hemophilia and unstable condition requiring primary treatment by the system (such as using a large amount of corticosteroids or Immunosuppressant, etc.); (4) Occupational acne caused by chemicals, acne caused by medicine; special types of acne such as fulminant acne, polymerized acne, mechanical acne, acne vulgaris, occupational acne, acne; (5) Patients with mental disease.

Design outcomes

Primary

MeasureTime frame
After 4 weeks of treatment, the clinical efficacy of the two groups;

Secondary

MeasureTime frame
After 2 weeks of treatment, the clinical efficacy of the two groups;The effective rate of TCM syndrome before and after treatment in both groups;The recurrence rate of the two groups within 3 months;

Countries

China

Contacts

Public ContactLinge Li

Shijiazhuang Hospital of Traditional Chinese Medicine

670344215@qq.com+86 15133196552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026